Reviewer recognition and excellence program (rrep)

Ended Awarded Last action

Contract number
75F40126F80067
Awardee
Awarding agency
Obligated
$144,999

Award facts

Contract value 100% obligated
$144,999.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
R499 Support- Professional: Other
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
West McLean, VA 22102, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration issued a delivery order to The Mitre Corporation on June 22, 2026, with a ceiling value of $144,999.00 under a cost-plus-fixed-fee pricing model.

The order supports the Reviewer Recognition and Excellence Program (RREP). Place of performance is West McLean, VA. Ultimate completion is scheduled for August 3, 2026. No set-aside was used for this delivery order.

Quick answers

Who was awarded contract 75F40126F80067?

75F40126F80067 was awarded to The Mitre Corporation by Food and Drug Administration (Department of Health and Human Services) on June 22, 2026.

How much is contract 75F40126F80067 worth?

The government has obligated $144,999 on 75F40126F80067.

Is contract 75F40126F80067 an order under another contract?

Yes. 75F40126F80067 is a delivery order under 75FCMC23D0004, an indefinite delivery contract.

Was contract 75F40126F80067 competed?

The extent of competition for 75F40126F80067 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award